GRACE Score Calculator

Calculate the GRACE in-hospital mortality score for acute coronary syndrome from eight admission variables.

100% FreeNo sign-upPrivate — runs in your browser
—

Result

Score
—
Category
—

Copied to clipboard

How to use this tool

1
Enter age, heart rate and pressure

Admission values: age in years, heart rate in bpm, systolic pressure in mmHg.

2
Enter creatinine

Serum creatinine in mg/dL on admission.

3
Score Killip class and binary items

Killip I-IV, plus cardiac arrest, ST deviation and raised cardiac enzymes.

4
Read total and risk band

Low (108 or below), intermediate (109-140) or high (above 140) in-hospital mortality risk.

Formula & worked example

GRACE in-hospital score = age points (0-100) + heart rate (0-46) + systolic pressure (0-58) + creatinine (1-28) + Killip (0-59) + cardiac arrest (39) + ST deviation (28) + elevated enzymes (14). Low 108 or below, intermediate 109-140, high above 140.

Age 65 (58), heart rate 90 (15), systolic 110 (43), creatinine 1.0 (7), Killip II (20), ST deviation (28) and raised enzymes (14) total 185, high risk with in-hospital mortality above 3%.

Limitations — read this before you rely on it

Educational use only. This tool is for education only and is not medical advice. Talk to a clinician about any result that worries you, and never change treatment because of a calculator result.

Frequently asked questions

A risk score from the Global Registry of Acute Coronary Events that estimates in-hospital and 6-month mortality after acute coronary syndrome from eight admission variables.

For in-hospital mortality: 108 or below is low (under 1%), 109-140 intermediate (1-3%), and above 140 high (over 3%).

Age contributes up to 100 points, and cardiogenic shock (Killip IV) 59 points; low systolic pressure is also heavily weighted because hypotension at presentation is ominous.

It informs it: in NSTE-ACS, high-risk scores support early invasive assessment within 24 hours under current guidelines, alongside other factors.

No. It gives population-level risk from the registry cohort; individual outcomes vary with treatment, comorbidity and frailty.